LifeMD (LFMD) Short term Debt (2013 - 2025)
LifeMD (LFMD) reported Short term Debt of $12.0 million for Q2 2025, up 88.85% on a YoY basis from $6.3 million in Q2 2024, and up 3.01% quarter-over-quarter from $11.6 million in Q1 2025.
LifeMD (LFMD) Short term Debt (2013 - 2025) Analysis & Trends
LifeMD has reported Short term Debt for 5 years, with the latest figure at $12.0 million in Q2 2025.
- For the quarter ending Q2 2025, Short term Debt rose 88.85% year-over-year to $12.0 million; the trailing twelve-month figure through Jun 2025 stood at $12.0 million (up 88.85% YoY), and the FY2024 full-year result was $8.4 million, changed N/A from the prior year.
- Short term Debt for Q2 2025 stood at $12.0 million, up from $11.6 million in the prior quarter.
- The five-year high for Short term Debt was $12.0 million in Q2 2025, with the low at $4.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | LifeMD | 226.03 Mn | 226.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 11.96 Mn |
| Mar 31, 2025 | 11.61 Mn |
| Dec 31, 2024 | 8.44 Mn |
| Sep 30, 2024 | 5.28 Mn |
| Jun 30, 2024 | 6.33 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2017 | 42,479.00 |
| Jun 30, 2017 | 955,014.00 |
| Mar 31, 2017 | 1.81 Mn |
| Dec 31, 2016 | 192,254.00 |
| Sep 30, 2013 | 10,200.00 |